These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7857713)

  • 21. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1beta and hypoxia in small cell lung cancer.
    Zhu YM; Bagstaff SM; Woll PJ
    Br J Cancer; 2006 Jun; 94(12):1936-41. PubMed ID: 16721367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?
    Nakanishi Y; Cuttitta F; Kasprzyk PG; Avis I; Steinberg SM; Gazdar AF; Mulshine JL
    Exp Cell Biol; 1988; 56(1-2):74-85. PubMed ID: 2846378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of transforming growth factor-beta secretion from malignant glioma cells by interleukin-1 beta.
    Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Nukui H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):145-50. PubMed ID: 8869149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.
    Plummer HK; Dhar MS; Cekanova M; Schuller HM
    BMC Cancer; 2005 Aug; 5():104. PubMed ID: 16109170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
    Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A
    J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
    Huber D; Philipp J; Fontana A
    J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
    Weiner RE; Avis I; Neumann RD; Mulshine JL
    J Cell Biochem Suppl; 1996; 24():276-87. PubMed ID: 8806110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of lung squamous cell carcinoma-derived T-cell suppressive factor.
    Yoshino I; Yano T; Miyamoto M; Yamada K; Kajii Y; Onodera K; Ishida T; Sugimachi K; Kimura G; Nomoto K
    Cancer; 1993 Oct; 72(8):2347-57. PubMed ID: 8402448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer cell lines.
    Zhang L; Cilley RE; Chinoy MR
    J Surg Res; 2000 Sep; 93(1):108-19. PubMed ID: 10945951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human small cell lung cancer cells express high affinity naloxone-insensitive [125I]-endorphin binding sites.
    Taylor JE
    Life Sci; 1995; 56(5):PL97-102. PubMed ID: 7837928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM; Webster SJ; Flower D; Woll PJ
    Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines.
    Sumitomo K; Kurisaki A; Yamakawa N; Tsuchida K; Shimizu E; Sone S; Sugino H
    Cancer Lett; 2000 Jul; 155(1):37-46. PubMed ID: 10814877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7.
    Dubinett SM; Huang M; Dhanani S; Economou JS; Wang J; Lee P; Sharma S; Dougherty GJ; McBride WH
    J Natl Cancer Inst; 1995 Apr; 87(8):593-7. PubMed ID: 7752257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression and biological activity of the heparin-binding growth-associated molecule (HB-GAM) in lung cancer cell lines.
    Jäger R; Noll K; Havemann K; Pflüger KH; Knabbe C; Rauvala H; Zugmaier G
    Int J Cancer; 1997 Nov; 73(4):537-43. PubMed ID: 9389569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours.
    Wegmann BR; Schöneberger HJ; Kiefer PE; Jaques G; Brandscheid D; Havemann K
    Eur J Cancer; 1993; 29A(11):1578-84. PubMed ID: 7692907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted blockade of TGF-β and IL-6/JAK2/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts.
    Shi J; Feng J; Xie J; Mei Z; Shi T; Wang S; Du Y; Yang G; Wu Y; Cheng X; Li S; Zhu L; Yang CS; Tu S; Jie Z
    Sci Rep; 2017 Aug; 7(1):8660. PubMed ID: 28819126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
    Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
    J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Nagasaka M; Isoe S; Nakano S; Nukui H
    Neurol Med Chir (Tokyo); 1995 Jul; 35(7):423-30. PubMed ID: 7477684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.